Skip to main content
letter
. 2017 Mar 14;18:123. doi: 10.1186/s13063-017-1843-5

Table 4.

Recurrence rate and median recurrence-free survival (RFS) for Keyhole Limpet Hemocyanin (KLH) and mitomycin C (MM) for group 1 and group 2

Treatment received Hospital groupa Recurrence rate (%) Median (weeks) 95% confidence interval
Lower bound Upper bound
KLH Group 1 74 84 64 103
Group 2 54 139 100 178
Mitomycin C Group 1 26 N/Ab N/Ab N/Ab
Group 2 39 297 152 442

aGroup 1 = 6 hospitals, Group 2 = 12 hospitals

bNot attainable